blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3164155

EP3164155 - TREPROSTINIL FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.12.2022
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  07.01.2022
FormerGrant of patent is intended
Status updated on  26.09.2021
FormerExamination is in progress
Status updated on  08.11.2019
FormerRequest for examination was made
Status updated on  07.04.2017
FormerThe international publication has been made
Status updated on  13.01.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
United Therapeutics Corporation
1040 Spring Street
Silver Spring, MD 20910 / US
[2017/19]
Inventor(s)01 / PHARES, Ken
7005 Bowater Crossing
Hillborough, North Carolina 27278 / US
02 / CHANG, Courtney
9205 Giralda Walk
Raleigh, North Carolina 27617 / US
 [2017/19]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/19]
Application number, filing date15731463.412.06.2015
[2017/19]
WO2015US35595
Priority number, dateUS201462011689P13.06.2014         Original published format: US 201462011689 P
[2017/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015192030
Date:17.12.2015
Language:EN
[2015/50]
Type: A1 Application with search report 
No.:EP3164155
Date:10.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2015 takes the place of the publication of the European patent application.
[2017/19]
Type: B1 Patent specification 
No.:EP3164155
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)International search report - published on:EP17.12.2015
ClassificationIPC:A61K47/32, A61K9/14, A61K31/557, A61K9/10, A61P9/12
[2021/39]
CPC:
A61K31/192 (EP,CN,KR,US); A61K45/06 (EP,CN,KR,US); A61K31/785 (EP,CN,KR,US);
A61K47/32 (EP,CN,KR,US); A61K47/585 (EP,KR,US); A61K9/0053 (KR,US);
A61K9/10 (EP,CN,KR,US); A61K9/20 (KR,US); A61K9/48 (KR,US);
A61P11/00 (EP,KR); A61P43/00 (EP,KR); A61P9/10 (EP,KR);
A61P9/12 (EP,KR); A61K2300/00 (KR) (-)
C-Set:
A61K31/192, A61K2300/00 (EP,CN,US);
A61K31/785, A61K2300/00 (US,CN,EP)
Former IPC [2017/20]A61K47/32, A61K9/10, A61K31/557, A61K9/14
Former IPC [2017/19]A61K47/32, A61K9/10, A61K31/557
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/19]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:TREPROSTINILFORMULIERUNGEN[2017/19]
English:TREPROSTINIL FORMULATIONS[2017/19]
French:FORMULATIONS DE TRÉPROSTINIL[2017/19]
Entry into regional phase12.01.2017National basic fee paid 
12.01.2017Designation fee(s) paid 
12.01.2017Examination fee paid 
Examination procedure12.01.2017Examination requested  [2017/19]
12.01.2017Date on which the examining division has become responsible
27.07.2017Amendment by applicant (claims and/or description)
13.11.2019Despatch of a communication from the examining division (Time limit: M06)
12.05.2020Reply to a communication from the examining division
27.09.2021Communication of intention to grant the patent
29.12.2021Fee for grant paid
29.12.2021Fee for publishing/printing paid
29.12.2021Receipt of the translation of the claim(s)
Opposition(s)10.11.2022No opposition filed within time limit [2023/03]
Fees paidRenewal fee
16.06.2017Renewal fee patent year 03
12.06.2018Renewal fee patent year 04
13.06.2019Renewal fee patent year 05
15.06.2020Renewal fee patent year 06
14.06.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.06.2015
AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
MK09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
[2024/22]
Former [2024/20]HU12.06.2015
AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2024/18]HU12.06.2015
AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2023/25]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2023/21]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE12.06.2022
LU12.06.2022
CH30.06.2022
LI30.06.2022
Former [2023/20]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE12.06.2022
Former [2023/10]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/08]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/01]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/49]AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/48]AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/47]AT09.02.2022
DK09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/46]AT09.02.2022
DK09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/42]AT09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/39]AT09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/36]AT09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/35]HR09.02.2022
LT09.02.2022
NL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
PT09.06.2022
Former [2022/34]LT09.02.2022
NL09.02.2022
NO09.05.2022
PT09.06.2022
Former [2022/33]LT09.02.2022
NO09.05.2022
Cited inInternational search[Y]WO2009048606  (FUISZ RICHARD C [US]);
 [Y]WO2009137066  (UNITED THERAPEUTICS CORP [US], et al);
 [Y]WO2009158010  (CONCERT PHARMACEUTICALS INC [US], et al);
by applicantUS4093657
 US4185088
 US4306075
 US4593073
 US5091175
 US5153222
 US5234953
 US5491397
 US5607669
 US5679717
 US5693675
 US5917007
 US5919832
 US5929184
 US6054486
 US6066678
 WO0057701
 US6129910
 US6190649
 US6203785
 US6271264
 US6294163
 US6433026
 US6441245
 US6517825
 US6521212
 US6528688
 US2003099711
 US6610283
 US6700025
 US6756117
 US6756033
 US2004151687
 US6784254
 US6803386
 US6809223
 US2005165111
 US7101916
 US7125547
 US7199157
 US2007098678
 US2007122375
 US7229613
 US2007190021
 US7384978
 US2008200449
 US7417070
 US2008261942
 US2008280986
 US2009036465
 US2009124697
 US2010076083
 US2010179235
 US7879909
 US2011152204
 US7999007
 WO2012009816
 US2012190888
 US8232316
 US2012197041
 US8242305
 US8252839
 US2012216801
 US8350079
 US8349892
 US2013022570
 US8410169
 US8461393
 US8481782
 US2013189215
 US8497393
 US8536363
 US2013261187
 US8563614
 US8597684
 US8609728
 US8653137
 US8658694
 US8748657
 US8747897
 US2014275262
 US2014275616
 US2014288314
 US8940930
 US8969409
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.